Close Menu

David Weitz and his team of Harvard University physicists are attempting to adapt microfluidics technology to sequence DNA, reports MIT's Technology Review. If they succeed, the price of sequencing a human genome could plummet to about $30. The technology, which was developed in Weitz's lab, uses picoliter droplets of water as test tubes, says Technology Review's Emily Singer. The droplets can be moved around on a microfluidics chip, injected with chemicals, and sorted based on their color.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.